Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT-EHA CAR-T 2019 | CAR T-cell therapy for solid cancers

Jürgen Kuball • 28 Feb 2019
EBMT-EHA CAR-T 2019

Jürgen Kuball MD, PhD, from the University Medical Center, Utrecht, Amsterdam, discusses the potential for CART-cell therapy in solid cancers, as well as the challenges involved in transitioning a treatment designed for hematological cancers to other forms of tumour-based cancers. Recorded at the 1st European CAR T-cell meeting in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).

More from Jürgen Kuball

1:12
Dual targeting of the cancer metabolome & stress antigens to improve efficacy of engineered T-cells
Jürgen Kuball • 17 Feb 2024
1:16
An update on the GoCART initiative: GoCART passports & new edition of the EBMT-EHA CAR-T handbook
Jürgen Kuball • 17 Feb 2024
0:48
Novel off-the-shelf CARs: where may these agents fit in the hemonc treatment landscape?
Jürgen Kuball • 10 Feb 2023
0:49
The promise of novel multivalent gamma-delta T-cells in the treatment of cancers
Jürgen Kuball • 10 Feb 2023
The content of VJHemOnc is intended for healthcare professionals